Fig. 1 · Structure

Documents & Downloads

Gallamine triethiodide

Cat. No. A10417 CAS 65-29-2

mAChR M2 antagonist

Gallamine Triethiodide is a mAChR M2 antagonist with pronounced cardioselectivity.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Bioactivity / Mechanism

Gallamine triethiodide shows probe-dependent allosteric modulation of native atrial M2 muscarinic receptors. In porcine membrane assays it slowed [3H]NMS dissociation, whereas [3H]QNB dissociation accelerated at lower gallamine concentrations and slowed at higher concentrations. The direction of the kinetic effect therefore depends on the orthosteric probe. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Target & Activity

Target Activity Value
AChR 68.0 μM

In Vitro Studies

In isolated rat skin–nerve preparations, gallamine triethiodide (10^−5 M) prevented the heat and mechanical desensitization induced by muscarine (10^−5 M). Gallamine alone caused no relevant threshold changes. This supports its use as a muscarinic antagonist in this ex vivo model; it does not demonstrate analgesic efficacy in animals. [2]

Probe-dependent allosteric effects at native atrial M2 receptors

Biochemical assay · M2 muscarinic receptors in sarcolemmal membranes from porcine atria; Figure 1A [1]

Gallamine slowed N-[3H]methylscopolamine dissociation. With [3H]quinuclidinylbenzilate, lower concentrations accelerated dissociation and higher concentrations slowed it. These paired kinetic profiles support probe-dependent allostery.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Radioligand dissociation rate normalized to the no-gallamine rate (kobsd/k0)Dissociation kinetics [3H]NMS: monotonic slowing; [3H]QNB: acceleration followed by slowing (bell-shaped profile).[1]

Literature-Reported Treatment Conditions

Treatment concentration
Graded gallamine concentrations; probes: [3H]NMS 1.0 nM or [3H]QNB 0.20 nM; atropine chase 3 μM.
Exposure duration
Probe preincubation: NMS 30 min at 24°C; QNB 60 min at 37°C.
Method
Gallamine added with atropine to initiate net dissociation. Binding assays used magnesium-free buffer B.
Vehicle
Ligands dissolved in assay buffer B.
Co-treatment
Radioligand and atropine are assay components; no therapeutic combination studied.
Reported limits
Exact post-chase sampling intervals are not specified in the retrieved main-text membrane protocol, which cites a previous method. No exact gallamine grid reconstructed from the curve.
Methods and source locations

Compound reported in the paper: Gallamine triethiodide; Compound label in the paper: Gallamine

Native receptor membrane assay; not a cellular response, animal treatment, IC50 determination, or proof of a unique receptor stoichiometry.

Experimental Procedures: Ligands, Detergents, and other Materials; Muscarinic Receptor from Porcine Atria; Binding Assays; Results Kinetics of Dissociation; Figure 1A; Table 1

Radioligand dissociation rate normalized to the no-gallamine rate (kobsd/k0): Atropine chase; two-point membrane binding assays. Figure 1A shows means ± SEM; Table 1: three NMS and five QNB experiments at the plotted probe concentrations, each with four or more gallamine concentrations and a no-gallamine control. — Results, Kinetics of Dissociation; Figure 1A and caption; Table 1 native atrial membrane rows and footnote a

Gallamine prevents muscarine-induced desensitization in isolated rat skin

Cell-based study · Isolated male Wistar rat hairy skin–saphenous nerve preparation; single C-fiber recordings [2]

Gallamine alone produced no relevant threshold change and prevented muscarine-induced heat and mechanical desensitization. The gallamine group comprised seven fibers (five heat-sensitive C-MH and two C-HTM). This is an ex vivo antagonism result, not evidence of analgesic efficacy.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Heat and von Frey mechanical thresholds before treatment, after gallamine, and after gallamine plus muscarineSensory threshold response No relevant threshold changes with gallamine alone or after muscarine co-application; mechanical n = 7 fibers, heat n = 5 C-MH fibers.[2]

Literature-Reported Treatment Conditions

Treatment concentration
Gallamine 10^−5 M; muscarine 10^−5 M.
Exposure duration
Gallamine superfusion for 5 min, followed by co-application with muscarine for an additional 5 min.
Method
Local superfusion of receptive fields in isolated skin at 32°C; sensory tests before and after application.
Vehicle
Synthetic interstitial fluid (SIF).
Co-treatment
Sequential gallamine alone then gallamine plus muscarine; scopolamine and 4-DAMP were separate comparator conditions.
Reported limits
Number of donor animals contributing to the seven-fiber gallamine group is not specified in the retrieved group description. Total preparation cohort is not assigned to this treatment.
Methods and source locations

Compound reported in the paper: Gallamine triethiodide; Compound label in the paper: Gallamine

Functional ex vivo sensory-neuron experiment. Pharmacological antagonism does not by itself establish exclusive M2 selectivity or in vivo analgesia.

Materials and Methods: General procedures, Chemical stimulation, Data analysis; Results: Controls, Muscarinic antagonists; Figures 3F and 5F

Heat and von Frey mechanical thresholds before treatment, after gallamine, and after gallamine plus muscarine: Single-fiber electrophysiology; Figures 3F and 5F compared with SIF controls and muscarine-alone groups. n denotes fibers, not independent animals. — Results: Controls, Muscarine, Muscarinic antagonists; Figures 3A/C/F and 5A/C/F and captions

Specifications

Manufacturer Adooq Bioscience
Actions Antagonist
CAS Number 65-29-2
Applications mAChR M2 antagonist
Formula C30H60I3N3O3
Molecular Weight 891.53
SMILES
CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-]

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 94 mg/mL (105.43 mM)
Water 94 mg/mL (105.43 mM)
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Research References

  1. [1] Rabindra V. Shivnaraine, Xi-Ping Huang, Margaret Seidenberg, et al. Heterotropic Cooperativity within and between Protomers of an Oligomeric M2 Muscarinic Receptor Biochemistry (2012). PMID: 22551249 DOI: 10.1021/bi3000287 Source material
  2. [2] Nadia Bernardini, Susanne K. Sauer, Rainer Haberberger, et al. Excitatory Nicotinic and Desensitizing Muscarinic (M2) Effects on C-Nociceptors in Isolated Rat Skin Journal of Neuroscience (2001). PMID: 11312314 DOI: 10.1523/JNEUROSCI.21-09-03295.2001 Source material

Added to your cart

View Cart Checkout
Loading...